Canadian Cancer Trials Group Bulletins


New pancreatic cancer trial provides hope to BC family

CCTG led PA.7 combines immunotherapy drugs with standard chemotherapy

An innovative clinical trial underway across Canada is providing new hope to a B.C. family braving pancreatic cancer - the deadliest cancer facing Canadians today.

The Canadian Cancer Trials Group (CCTG), PA.7 clinical trial combines cutting-edge immunotherapy drugs with standard chemotherapy - a successful mix for treating certain cancers such as kidney and lung - to treat pancreatic cancer, which has the lowest survival rate of all, according to a June report from the Canadian Cancer Society.

Read more: